HELIOS PHARMA LIMITEDActive

Company number 07941606Private limited companyIncorporated 2012

Key figures

£38,611-27.0%
Net assets 2024/25
-18.1%
Average annual change 2020/21–2024/25
050 k100 k150 k2020/212021/222022/232023/242024/25

Like most small UK companies, HELIOS PHARMA LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand22,01063,14857,23978,23354,775
Total assets263,671299,004274,205314,234158,945
Total liabilities177,713191,658199,807261,354120,334
Net assets / total equity85,958107,34674,39852,88038,611
Average number of employees22266

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: HELIOS PHARMA LIMITED

Company

HELIOS PHARMA LIMITED is a private limited company registered with Companies House under company number 07941606. It was incorporated on 8 Feb 2012. Its status is active. The registered office is in Sheffield (S35). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2024/25 (period ending 28 Feb 2025); the company files abridged accounts (unaudited). Net assets were £38,611, down 27% on the previous year. Cash at bank and in hand was £54,775. Total assets were £158,945 and total liabilities £120,334. The company had an average of 6 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

3 persons with significant control are registered. 3 of 3 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Nov 2026. The next confirmation statement is due by 2 Nov 2026.